RSV: The First Specimens

A hen's leg with osteochondrosarcoma, circa 1912 Credit: © Jason varney | Varneyphoto.com" />A hen's leg with osteochondrosarcoma, circa 1912 Credit: © Jason varney | Varneyphoto.com It was not odd that an upstate New York farmer would bring a sick Plymouth Rock hen to Peyton Rous at the Rockefeller Institute in 1909, nor that Rous would be interested in the case. Two years earlier, Hungarian veterinarian Joseph Marek had identified the costly, highly transmissible visceral

Written byTerry Sharrer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

It was not odd that an upstate New York farmer would bring a sick Plymouth Rock hen to Peyton Rous at the Rockefeller Institute in 1909, nor that Rous would be interested in the case. Two years earlier, Hungarian veterinarian Joseph Marek had identified the costly, highly transmissible visceral leucosis of the chicken which now bears his name, and a pair of Danish researchers had identified the viral etiology of a chicken leukemia in 1908. Might the chicken hold a revelation about viral-inducing tumors in humans? Rous wondered, even as conventional medical wisdom strongly rejected that possibility.

In Rous's first line of experiments, he transplanted bits of the original hen's breast tumor to other purebred Plymouth Rocks and mixed-bred chickens, producing tumors in the purebred stock alone--which suggested an inherited susceptibility (J Exp Med, 12:696-705, 1910). Subsequently, he demonstrated transmission of malignant new growth from a cell-free filtrate, and how ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies